TEVA FY 2013 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$35B

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$20.3B-0.0% YoY

Gross Profit

$10.7B52.7% margin

Operating Income

$1.6B8.1% margin

Net Income

$1.3B6.2% margin

EPS (Diluted)

$1.49

Cash Flow

Operating Cash Flow

$3.2B

Free Cash Flow

$2.2B

Stock-Based Comp.

$64M

Balance Sheet

Total Assets

$47.5B

Total Liabilities

$24.9B

Stockholders' Equity

$22.6B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20.3B	$20.3B	-0.0%
Gross Profit	$10.7B	$10.7B	+0.5%
Operating Income	$1.6B	$2.2B	-25.2%
Net Income	$1.3B	$2.0B	-35.4%